Choriocarcinoma with pulmonary metastasis: Report of a case of successful treatment with serial FDG-PET follow-up

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 52, Issue 5, 2007, Pages 450-452

  Chang, Wei Chun ^a   Hung, Yao Ching ^a   Shen, Huang Ping ^a   Kao, Chia Hung ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Choriocarcinoma; Lung neoplasms; Metastasis; Positron emission tomography

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; METHOTREXATE; VINCRISTINE SULFATE;

ACCURACY; ADULT; ARTICLE; CANCER STAGING; CASE REPORT; CHORIOCARCINOMA; DECISION MAKING; FEMALE; HUMAN; LUNG METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR LOCALIZATION; VAGINAL HYSTERECTOMY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHORIOCARCINOMA; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; HYSTERECTOMY; LUNG NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREGNANCY; RADIOPHARMACEUTICALS; UTERINE NEOPLASMS;

EID: 34249109376     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bomanji JB, Costa DC, Ell PJ: Clinical role of positron emission tomography in oncology. Lancet Oncol 2001;2:157-164
2. Bagshawe KD: Introduction. In Gestational Trophoblastic Disease. Edited by BW Hancock, ES Newlands, RS Berkowitz. Cambridge, Chapman & Hall, 1997, pp 1-4
3. Bolis G, Bonazzi C, Landoni F, et al: EMA-CO regimen in high risk gestational trophoblastic tumor (GTT). Gynecol Oncol 1988;31:439-444
4. Hammond CB, Weed JC Jr, Currie JL: The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol 1980;136:844-858
5. Surwit EA, Childers JM: High- risk metastatic gestational trophoblastic disease: A new dose-intensive multiagent chemotherapeutic regimen. J Reprod Med 1991;36:45-48
6. Strauss LG , Conti PS: The application of PET in clinical oncology. J Nucl Med 1991;32:623-648
7. Grigsby PW, Siegel BA, Dehdashti F, et al: Post therapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiat Oncol Biol Phys 2003;55:907-913
8. Zimmy M, Siggelkow W, Schröder W, et al: 2-(Fluorine-18)-Fluoro-2- deoxy-D-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol 2001;83:310-315
9. Saga T, Higsh T, Ishimori T, et al: Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer. Ann Nucl Med 2003;17:193-203
10. Cohn DE, Dehdashti F, Gibb RK, et al: Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol 2002;85:179-184
11. Hebart H, Erley C, Kaskas B, et al: Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma. Ann Oncol 1996;7:416-418
12. Sironi S, Picchio M, Mangili G, et al: (18 F)-fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: Preliminary results in three patients. Gynecol Oncol 2003;91:226-230
13. Numnum TM, Leath CA III, Straughn JM, et al: Occult choriocarcinoma discovered by positron emission tomography/computed tomography imaging following a successful pregnancy. Gynecol Oncol 2005;97:713-715